Peptide Having Activity of Skin Whitening and Uses Thereof
A novel peptide targeting PAR2, TLR3, and KGFR in keratinocytes addresses the limitations of existing skin whitening agents by inhibiting melanosome uptake, effectively treating and preventing hyperpigmentation disorders through diverse mechanisms.
Patent Information
- Application Number
- KR1020230138104
- Authority / Receiving Office
- KR · KR
- Patent Type
- Patents
- Current Assignee / Owner
- Filing Date
- 2023-10-16
- Publication Date
- 2026-11-10
- Estimated Expiration
- 2043-10-16
AI Technical Summary
Existing skin whitening agents primarily focus on inhibiting the activity of tyrosinase, a key enzyme in melanin synthesis, lacking diversity in mechanisms of action, and there is a need for agents with different sites of action to achieve synergistic effects.
A novel peptide with the amino acid sequence SEQ ID NO. 1 is developed, which inhibits the uptake of melanosomes into keratinocytes by targeting PAR2, TLR3, and KGFR, providing an alternative mechanism for skin whitening.
The peptide effectively inhibits melanosome uptake in keratinocytes, reducing hyperpigmentation disorders such as melasma and age spots by inhibiting TLR3 and KGFR gene expression, offering a therapeutic and preventive solution for skin whitening.
Smart Images

Figure 112023113290296-PAT00001_ABST
Abstract
Citation Information
Patent Citations
Peptide for Skin Whitening and Use Thereof
KR101841742B1
Peptide having activities of skin whitening and uses thereof
KR102265432B1
